Marshall Wace’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Marshall Wace's VRTX Position: Q2 2026 in Review
Marshall Wace increased its Vertex Pharmaceuticals (VRTX) stake by 72% in Q2 2026, buying an estimated $101M and bringing the position to 543,897 shares worth $270M. The position accounts for 0.21% of the portfolio, ranked #64.
Marshall Wace first reported a position in VRTX in Q2 2014 and has held it in 42 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Marshall Wace held 543,897 shares of Vertex Pharmaceuticals worth $270M as of Q2 2026.
- Marshall Wace bought 226,839 Vertex Pharmaceuticals shares in Q2 2026, an estimated $101M.
- Vertex Pharmaceuticals made up 0.21% of Marshall Wace's portfolio in Q2 2026, its #64 holding.
- Marshall Wace first reported a position in Vertex Pharmaceuticals in Q2 2014 and has held it in 42 quarters since.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.